Clinical Trial Update: Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse [Phase 3]

View source ↗

Summary

Phase 3 trial assessing rapid antisuicidal effects of intranasal ketamine in individuals with comorbid depression and alcohol use disorder completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder
• Suicidal Ideation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Suicidal Ideation, Depression | Phase 3 | Status: COMPLETED | Results posted: 2023-03-01